| Title |
Economic Evaluation of Ropinirole Prolonged Release for Treatment of Parkinson’s Disease in The Netherlands
|
|---|---|
| Published in |
Drugs & Aging, January 2014
|
| DOI | 10.1007/s40266-013-0150-4 |
| Pubmed ID | |
| Authors |
Job F. M. van Boven, Annoesjka Novak, Maurice T. Driessen, Cornelis Boersma, Maarten M. Boomsma, Maarten J. Postma |
| Abstract |
By using the findings obtained from the PREPARED study, we aimed to estimate the cost effectiveness of ropinirole prolonged release (PR) [Requip-Modutab(®)] in Parkinson's disease (PD) versus ropinirole immediate release (IR). In the PREPARED study, ropinirole PR provided a significantly greater improvement in time spent 'off' than ropinirole IR when used as an add-on to levodopa. |
Mendeley readers
The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 3% |
| Sweden | 1 | 3% |
| Unknown | 32 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 6 | 18% |
| Student > Bachelor | 4 | 12% |
| Researcher | 4 | 12% |
| Student > Doctoral Student | 3 | 9% |
| Other | 3 | 9% |
| Other | 5 | 15% |
| Unknown | 9 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 47% |
| Pharmacology, Toxicology and Pharmaceutical Science | 3 | 9% |
| Nursing and Health Professions | 2 | 6% |
| Psychology | 2 | 6% |
| Economics, Econometrics and Finance | 2 | 6% |
| Other | 0 | 0% |
| Unknown | 9 | 26% |